Marco Sgarbanti
Italian National Institute of Health, Italy
Biography
Dr. Marco Sgarbanti has studied molecular virus-host interaction for 15 years as deducible by hispeer-reviewed publications. As researcher and principal investigator (PI), he has been studying the role of cellular transcription factors in HIV-1 LTR expression focusing on strategies aimed at eliminating viral reservoirs. Recently he has focused in the development of cellular assays suitable for high throughput screening (HTS) of small molecules, to find inhibitors of RNA viral proteins belonging to important human threatening virus diseases. Awards: winner of a Grand Challenges Exploration Grant in Global Health, Phase I,of the Bill & Melinda Gates Foundation.